Latest Diabetic retinopathy Stories
TARRYTOWN, N.Y. and BERLIN, June 7, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
MARLOW, England, June 6, 2011 /PRNewswire/ -- Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX(R) (dexamethasone 0.7mg intravitreal implant in applicator) for the treatment of macular oedema due to central retinal vein occlusion (CRVO) and also for branch retinal vein occlusion (BRVO) where laser photocoagulation is neither beneficial nor appropriate. RVO is an eye condition that can lead to severe damage to the...
People who are deaf benefit from better vision due to the fact their retinas develop differently, experts at the University of Sheffield have shown.
The Hong Kong Polytechnic University (PolyU) has set a record of reaping 10 prizes at the 39th International Exhibition of Inventions of Geneva, with an array of innovations which range from myopia-retarding contact lenses to DNA Bio-sensor and solar energy device. (PRWEB) May 20, 2011 The Hong Kong Polytechnic University (PolyU) has set a record of reaping 10 prizes at the 39th International Exhibition of Inventions of Geneva, with an array of innovations which range from myopia-retarding...
MOUNTAIN VIEW, Calif., May 4, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that leading clinicians have performed and published the results of a new study* that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME).
TARRYTOWN, N.Y., May 2, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Bank of America Merrill Lynch 2011 Health Care Conference on Tuesday, May 10, 2011 at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time).
WPI Communications announces the launch of a new publication for ophthalmologists. Short Hills, NJ (PRWEB) April 29, 2011 WPI Communications, an editorial and communications firm specializing in helping professionals increase revenue through expanded referrals, announced today the launch of Retina Update, a personalized quarterly educational newsletter designed to grab the attention of referring non-ophthalmic physicians.
TARRYTOWN, N.Y. and BERLIN, April 27, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
WEST PALM BEACH, Fla., April 25, 2011 /PRNewswire/ -- The ophthalmic therapeutics company Xcovery Vision announced today that Sheridan G. Snyder, OBE, Chairman and CEO, and Dr.
Prospects for recovery of lost vision have brightened with the release of new scientific findings showing that the use of gentle near infra-red light can reverse damage caused by exposure to bright light, up to a month after treatment.
- A transitional zone between two communities containing the characteristic species of each.